GalbraithWight is a specialist global Market Access consultancy. Our team of expert practitioners design and deliver consulting and training solutions for the global healthcare industry. We deliver tailored solutions in three key areas; Market Access, Brand & Launch Excellence, and Insight Market Research.

We help healthcare companies improve lives and create value through the successful commercialisation of their products.

Market Access

Hand world

Global Market Access is the single most important determinant of commercial success for healthcare companies today, and the biggest hurdle to be overcome in the delivery of the latest advancements in care to patients.

View details »

Insight Market Research

Market research

Our Insight Market Research programme arms you with the knowledge and insights to launch your new brand successfully. We help our clients answer their critical Market Access questions so that risk is minimised and patients can receive the innovative new care they need as quickly as possible.

View details »

Brand & Launch Excellence

Business strategy

The successful launch of any new pharmaceutical brand must take into account the critical dimensions of brand, company and market. But most importantly of all, a coherent Market Access strategy must lie at the heart of all business and brand planning.

View details »

Latest News

GalbraithWight will be attending the ABPI Annual Conference – “New Medicines – Better Outcomes?” on April 21st, 2016, at 155 Bishopsgate, London, United Kingdom

The conference has an impressive line-up of speakers including George Freeman, M.P., Parliamentary Undersecretary of State for Life...

read more

Colin Wight, CEO presents at Pharma Pricing & Market Access 2016 Congress London

Colin Wight, Chief Executive of GalbraithWight presents ‘Things that go horribly wrong in the practice of market...

read more

GalbraithWight at the ISPOR 18th Annual European Congress, Milan.

  GalbraithWight participates in the ISPOR 18th Annual European Congress, 8th – 11th November at the Mico – Milano...

read more

GalbraithWight at the 3rd Annual External Collaborations for Innovation in Pharma & Biotech East, Boston, USA.

GalbraithWight exhibits at the 3rd Annual External Collaborations for Innovation in Pharma & Biotech - East at the Hyatt Regency,...

read more

Our Clients

  • Abbvie
  • Astellas
  • Astrazeneca
  • Boehringer
  • B ms
  • Celgene
  • Cubist
  • Eisai
  • Ferring
  • Gilead
  • Gsk
  • Lundbeck
  • Merckserono
  • Merckco
  • Novartis
  • Otsuka
  • Pfizer
  • Roche
  • Sanofi
  • Spmsd
  • Ucb
  • Halozyme
  • Chiesi logo
  • Leopharma
  • Janssen

Latest news

GalbraithWight will be attending the ABPI Annual Conference – “New Medicines – Better Outcomes?” on April 21st, 2016, at 155 Bishopsgate, London, United Kingdom

The conference has an impressive line-up of speakers including George Freeman, M.P., Parliamentary Undersecretary of State for Life...

read more

Colin Wight, CEO presents at Pharma Pricing & Market Access 2016 Congress London

Colin Wight, Chief Executive of GalbraithWight presents ‘Things that go horribly wrong in the practice of market...

read more

Contact Us

GalbraithWight has offices located in the UK, Princeton NJ and Milan.

Full contact details can be found here